Unknown

Dataset Information

0

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.

ABSTRACT:

SUBMITTER: Hunault-Berger M 

PROVIDER: S-EPMC5520397 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia.
| S-EPMC5777197 | biostudies-literature
Unknown Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia.
| S-EPMC6442982 | biostudies-literature
Unknown Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia.
| S-EPMC8759135 | biostudies-literature
Unknown Efficacy of Venetoclax Combined with Azacitidine in Elderly Patients with Relapsed Acute Myeloid Leukemia.
| S-EPMC12422247 | biostudies-literature
Unknown Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts.
| S-EPMC7248154 | biostudies-literature
Unknown Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
| S-EPMC6318429 | biostudies-literature
Unknown Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.
| S-EPMC5684733 | biostudies-literature
Unknown Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study.
| S-EPMC3677141 | biostudies-literature
Unknown Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia.
| S-EPMC10332158 | biostudies-literature
Unknown Azacitidine as maintenance therapy in pediatric <i>de novo</i> acute myeloid leukemia.
| S-EPMC12714944 | biostudies-literature